Agnieszka Rawluszko-Wieczorek

Has grant

Assistant Professor

Poznan University of Medical Sciences

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Agnieszka Rawluszko-Wieczorek is an Assistant Professor at Poznan University of Medical Sciences, Poland. Her research areas include cancer biology with a focus on ovarian cancer, tumorigenesis, and epigenetics. She has contributed to recent studies on the role of drug resistance in cancer treatment and the genetic factors influencing patient outcomes through analyses of large-scale genomic data.

Recent Grants

Grant: Close

Reading of lysine methylation – discovery, biological function and application

Open Date: 2015-10-01

Close Date: 2017-09-30

Articles (7)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Collaborators (5)

Michal Nowicki

Head of Department

Poznan University of Medical Sciences

POLAND

View details

Karolina Sterzyńska

Poznan University of Medical Sciences

POLAND

View details

Radoslaw Januchowski

University of Zielona Góra

POLAND

View details

Wiktoria M. Suchorska

Poznan University of Medical Sciences

POLAND

View details

Jan Korbecki

University of Zielona Góra

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Agnieszka Rawluszko-Wieczorek

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (7)

Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs

The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models

Genes Co-Expressed with <i>ESR2</i> Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis

Understanding Hypoxia-Driven Tumorigenesis: The Interplay of HIF1A, DNA Methylation, and Prolyl Hydroxylases in Head and Neck Squamous Cell Carcinoma

Assessment of TET1 gene expression, DNA methylation and H3K27me3 level of its promoter region in eutopic endometrium of women with endometriosis and infertility

The m<sup>6</sup>A RNA Modification Quantity and mRNA Expression Level of RNA Methylation-Related Genes in Head and Neck Squamous Cell Carcinoma Cell Lines and Patients

Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape

Collaborators (5)

Michal Nowicki

Karolina Sterzyńska

Radoslaw Januchowski

Wiktoria M. Suchorska

Jan Korbecki

Make your next move.